180 related articles for article (PubMed ID: 29572256)
1. Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.
Montemagno C; Bacot S; Ahmadi M; Kerfelec B; Baty D; Debiossat M; Soubies A; Perret P; Riou L; Fagret D; Broisat A; Ghezzi C
J Nucl Med; 2018 Jul; 59(7):1056-1062. PubMed ID: 29572256
[TBL] [Abstract][Full Text] [Related]
2. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
3. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
4.
Montemagno C; Cassim S; Trichanh D; Savary C; Pouyssegur J; Pagès G; Fagret D; Broisat A; Ghezzi C
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658755
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors.
Misri R; Saatchi K; Ng SS; Kumar U; Häfeli UO
Nucl Med Biol; 2011 Aug; 38(6):885-96. PubMed ID: 21843785
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
7. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
8. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
13. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
Felix DD; Gore JC; Yankeelov TE; Peterson TE; Barnes S; Whisenant J; Weis J; Shoukouhi S; Virostko J; Nickels M; McIntyre JO; Sanders M; Abramson V; Tantawy MN
Nucl Med Biol; 2015 Mar; 42(3):269-73. PubMed ID: 25533764
[TBL] [Abstract][Full Text] [Related]
14. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
15. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer.
Montemagno C; Dumas L; Cavaillès P; Ahmadi M; Bacot S; Debiossat M; Soubies A; Djaïleb L; Leenhardt J; Leiris N; Dufies M; Pagès G; Hernot S; Devoogdt N; Perret P; Riou L; Fagret D; Ghezzi C; Broisat A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31340603
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
[TBL] [Abstract][Full Text] [Related]
18. Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer.
Shao F; Pan Z; Long Y; Zhu Z; Wang K; Ji H; Zhu K; Song W; Song Y; Song X; Gai Y; Liu Q; Qin C; Jiang D; Zhu J; Lan X
J Nanobiotechnology; 2022 May; 20(1):243. PubMed ID: 35614462
[TBL] [Abstract][Full Text] [Related]
19. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
Liu C; Guo Z; Zhang P; Song M; Zhao Z; Wu X; Zhang X
Nucl Med Biol; 2014 Aug; 41(7):587-93. PubMed ID: 24815356
[TBL] [Abstract][Full Text] [Related]
20. Development of
Rainone P; Riva B; Belloli S; Sudati F; Ripamonti M; Verderio P; Colombo M; Colzani B; Gilardi MC; Moresco RM; Prosperi D
Int J Nanomedicine; 2017; 12():3447-3461. PubMed ID: 28496321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
